If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 1 Jun: IAVI to advance vaccine candidate for Bundibugyo virus, receives funding from CEPI
• 29 Jun: Optimizing antibodies for antimicrobial resistance
• 24 Apr: Kim Johnson MP visits malaria researchers ahead of World Malaria Day
• 14 Apr: Closing the Gap Between Impact and Innovation
• 24 Apr: Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments
• Jun 8: DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
• 2 Jul: From innovation to access: ensuring lifesaving solutions reach those who need them
• 5 Jun: Coartem® Baby awarded MMV’s Project of the Year 2025
• 8 Jun: DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
• 17 Jun: MMV and DNDi pool regulatory expertise to accelerate access to lifesaving medicines
• 29 Jun: African manufacturers’ perspectives on the successes, challenges and expected benefits of producing quality-assured antimalarials
• 8 Jun: DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
• 9 Jun: DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
• 12 Jun: DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
• 17 Jun: MMV and DNDi pool regulatory expertise to accelerate access to lifesaving medicines
• 29 Jun: Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors
• 9 Apr: Dr Ayoade Alakija Appointed to the Accra Reset initiative
• 8 Jun: IVI partners in ACT-CHIK consortium to advance chikungunya vaccine development and manufacturing in Africa
• 26 Jun: IVI, KDCA, and RIGHT Foundation host 2026 Global Vaccine Forum on advancing equitable access to next-generation vaccines
MDGH
• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction
PDP Funder News/Announcements
• 3 Jun: UK launches expert network to boost Ebola response and global crisis readiness. UK Government
• 15 Jun: Novo Nordisk Foundation and Global Health EDCTP3 launch funding partnership to advance global health research. EDCTP3
• 17 Jun: GHIT Fund kick-started emergency product development support for Ebola disease outbreak caused by Bundibugyo virus. GHIT
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 29 Jun: Advancing global health innovation through Europe-Africa collaboration. Numerous PDPs
Other Reports/ Publications
• Jun: From innovation to impact: Building on 20 years of progress. Unitaid
• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies
Related Press Releases/ Announcements/Articles
• 1 Jul: Study reveals path for universal vaccine against malaria. OHSU
• 1 Jul: Gavi launches new supply chain strategy to boost vaccine availability and reach remote communities. Gavi
• 1 Jun: Debugging: Google requests permission to release 32m mosquitoes in California and Florida. The Guardian
• 1 Jun: The race is on to develop Bundibugyo Ebola vaccines. Devex
• 1 Jun: Offline: The dishonest politics of global health, Richard Horton. The Lancet
• 1 Jun: Charting Ebola Responses: How 2026 Stacks Up After Aid Cuts. Think Global Health
• 1 Jun: Africa CDC: Ebola Emergency Underscores The Access to Countermeasures in the Negotiations On Pathogen Access & Benefit Sharing. Geneva Health Files
• 1 Jun: As Ebola Spreads, Scientists Race to Find Vaccines and Treatments. The New York Times
• 2 Jun: Only the Right Tests Can Stop This Ebola Outbreak. Congo Has Hardly Any. The New York Times
• 2 Jul: Ebola Antiviral Trial Begins at Secret Facility Amid Attacks on Treatment Centres. Health Policy Watch
• 2 Jul: Financial innovation can deliver a Bundibugyo Ebola vaccine. Nature
• 2 Jun: Phase 1 clinical trial set to begin on first leishmaniasis vaccine. Ohio State News
• 2 Jun: Can Africa pay for its own outbreaks? Ebola offers an early test. Devex
• 2 Jun: Tuberculosis test may improve diagnosis. NIH
• 2 Jun: The Chagas disease time bomb in Latin America’s cities. The Telegraph
• 2 Jun: Collaboration will be key in race for vaccine to control rare Ebola strain. Gavi
• 2 Jun: Scientists identify possible cause of noma, the disease that destroys children’s faces. Gavi
• 2 Jun: Rubio says US is considering naming official to run Ebola response. Reuters
• 2 Jun: Better diagnostics could have limited this Ebola outbreak. Nature
• 2 Jun: Rubio Suggests U.S. Return to Global Vaccine Program in Rebuke of Kennedy. The New York Times
• 3 Jun: This Is Why You Don’t Slash Humanitarian Aid. The New York Times
• 3 Jul: Modeling time-varying efficacy of RTS,S/AS01 malaria vaccine across trial settings. Nature
• 3 Jul: The key to innovative financing in low- and middle-income countries. Devex
• 3 Jun: White House may appoint Ebola lead, Rubio tells lawmakers. Devex
• 3 Jun: NIH cuts weakened network primed to respond to outbreaks like Ebola. STAT
• 3 Jun: WHO: Sharp Decline in Number of Suspected Ebola Bundibugyo Virus Cases as Numbers are Refined. Health Policy Watch
• 3 Jun: Malaria is gaining ground—but researchers are developing promising new solutions. Harvard
• 3 Jun: Scientific Breakthroughs and Political Retreat Set the Stage for a Crucial Global Moment in the Fight Against HIV/AIDS. Global Dispatches
• 3 Jun: Implementation determinants of rapid diagnostics tests for fever management in sub-Saharan Africa: a mixed-studies systematic review. Nature
• 4 Jul: How CEPI can enhance global vaccine equity and transparency. The Lancet
• 5 Jun: Accelerating vaccine research and development for skin neglected tropical diseases: A case for leishmaniasis, leprosy, and Buruli ulcer. PLOS
• 5 Jun: Durability of the insecticidal activity of next-generation insecticide treated nets distributed for malaria control in Mozambique: Findings from the New Nets Project (2020–2022). PLOS
• 5 Jun: From market failure to epidemic preparedness: the race for a Bundibugyo Ebola vaccine. Gavi
• 5 Jun: What the Ebola outbreak demands from global leaders in 2026. Gavi
5 Jun: The fatal Ebola outbreak in the DRC needs faster, simpler tests. Devex
• 5 Jun: Ghana eyes 2027 launch of first locally produced vaccine with $50 million investment push. Pulse
• 5 Jun: WHO and Africa CDC Launch Joint Ebola Response Plan Amid Serious Local Challenges. Health Policy Watch
• 6 Jun: Responding to Ebola: a test. The Lancet
• 7 Jun: Tanzania's bold experiment against malaria. DW
• 8 Jun: Non-Profit R&D Groups Pool Resources Amid Shrinking Global Budgets. Health Policy Watch
• 8 Jun: FG targets new tools to tackle malaria scourge. The Guardian Nigeria
• 8 Jun: Gavi plans to use US cash for malaria, while meeting Kennedy's conditions. Reuters
• 8 Jun: The Power of Science for Health: Malawi’s Milestones Transforming Lives. WHO
• 8 Jun: As climate shifts, malaria gains ground in southern Africa. MedicalXpress
• 8 Jun: Can We Win the Malaria Arms Race?. Health Policy Watch
• 8 Jun: CEPI awards Public Health Vaccines US$1.9m to accelerate Bundibugyo ebolavirus vaccine. CEPI
• 8 Jun: How CEPI can enhance global vaccine equity and transparency. The Lancet
• 8 Jun: Inclusion of young adolescents in policy development for new tuberculosis vaccines. The Lancet
• 8 Jun: Accelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project. First Word Pharma
• 8 Jun: Inside WHO and Africa CDC’s $518M Ebola response plan. Devex
• 9 Jun: Seth Berkley has seen our pandemic future. Devex
• 9 Jun: New TB vaccines are on the horizon. In Zambia, scientists are already figuring out how best to deploy it. Gavi
• 9 Jun: World’s first AI‑designed vaccine explained. Gavi
• 9 Jun: Muyembe: DRC’s Ebola Response Must Be Anchored Locally. Health Policy Watch
• 9 Jun: Lenacapavir: the HIV Breakthrough Proving Why NIH Funding Matters. Think Global Health
• 9 Jun: Bundibugyo Ebola without vaccines or therapeutics: why public health fundamentals matter more than border closures. Nature
• 9 Jun: To reset global development, invest in global south research and innovation. Devex
• 9 Jun: First-in-human clinical trial shows promising results for new Lassa fever vaccine. University of Maryland
• 9 Jun: CEPI awards Public Health Vaccines US$1.9m to accelerate Bundibugyo ebolavirus vaccine. CEPI
• 10 Jun: The hunt for a new Ebola vaccine: two scientists explain the challenges. The Conversation
• 10 Jun: First-Ever Dual Vaccine for Lassa Virus and Rabies Deemed Safe in Human Trial. Discover Magazine
• 10 Jun: Rwanda: €15m Vaccine Clinical Trial On Mosquito-Borne Viral Disease Launched. All Africa
• 10 Jun: Can global health reform without creating new fragmentation?. Devex
• 10 Jun: Did US aid cuts break precisely the things we need most for the lenacapavir rollout? Spotlight
• 10 Jun: Trump administration has its sights set on destroying international research collaborations. BMJ
• 11 Jun: FG deploys new tools to tackle malaria scourge. The Guardian Nigeria
• 11 Jun: The Gates Foundation’s push for stronger African health product regulators. Devex
• 11 Jun: Reforming the Global Health Architecture: Power Relations, Jockeying for Influence, and the Efforts to Break Free from Status Quo. Geneva Health Files
• 12 Jun: ‘It’s possible to have a collective success’: three Geneva health non-profits bolster ties amid shrinking aid. Geneva Solutions
• 12 Jun: Saving Women From Bleeding to Death After Giving Birth. Health Policy Watch
• 12 Jun: New pan-European network to develop novel diagnostics for infectious diseases. 360Dx
• 12 Jun: Global antimicrobial resistance threats forecast to rise by 2050, King’s College study finds. Innovation News Network
• 12 Jun: US to provide $50 mln more in funding to counter Ebola outbreak. Reuters
• 13 Jun: GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial. The Globe & Mail
• 13 Jun: Urgent need for a reliable rapid diagnostic test for the Ebola epidemic caused by Bundibugyo virus in Africa. The Lancet
• 14 Jun: Inside the race to develop a new Ebola vaccine. Scientific American
• 14 Jun: Leading Malaria Scientist Warns Tools Alone Will Not End the Disease. Health Policy Watch
• 15 Jun: Advances in the development of malaria vaccines. BMJ
• 15 Jun: US Support for Ebola Response is Unclear Amid Opaque Funds Disbursement and Non-Engagement with WHO. Health Policy Watch
• 15 Jun: WHO issues first ever guidance to advance child-focused dengue treatments. WHO
• 15 Jun: What Will It Take to Get a Bundibugyo Vaccine?. Johns Hopkins
• 16 Jun: Global Fund partners with CIFF to bring new TB tests to 13 countries. Devex
• 16 Jun: What the hantavirus and Ebola outbreaks tell us about pandemic preparedness. Nature
• 17 Jun: Could a hantavirus vaccine be on the horizon?. Gavi
• 17 Jun: EU supports Ebola response with €493 million in vaccines, treatment and health aid. Reuters
• 17 Jun: AI tool could speed antibiotic development. Health Research Matters
• 17 Jun: Beyond bread and beer: Alluring yeast species could yield new mosquito traps to combat malaria. Johns Hopkins University
• 17 Jun: Advocacy groups urge US to share experimental Ebola drug for outbreak trials. Reuters
• 17 Jun: Opinion: Global health reform must bolster innovation. Project Syndicate
• 17 Jun: Medical innovation in LMICs: can India lead the way?. Nature
• 18 Jun: Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July. Reuters
• 18 Jun: Ebola response received less than 10% of pledges, Africa CDC says. Reuters
• 18 Jun: US CDC activates $107 million in emergency funding for Ebola response. Reuters
• 18 Jun: Can market shaping improve medicine access across Africa?. Resolve
• 18 Jun: What happens when the world’s best HIV prevention tool meets the planet’s deadliest infectious disease?. Bhekisisa
• 18 Jun: Is Kenya’s lenacapavir rollout missing young women and girls?. Devex
• 19 Jun: Rollout of 5,000 near point-of-care TB test systems in 13 countries begins with $50M in funding. 360Dx
• 19 Jun: Africa CDC chief says the continent needs to invest its own funds in Ebola response, vaccine. AP
• 19 Jun: The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years. Wired
• 19 Jun: Instituting solidarity: the role of research institutes in advancing global health equity. Health Research & Policy Systems
• 20 Jun: Rapid tests for Bundibugyo virus in DR Congo. The Lancet
• 22 Jun: African vaccine manufacturing is advancing, but the path to market has revealed challenges. CHAI
• 22 Jun: Inequities in HIV prevention: strategic access and equity in injectable PrEP distribution. The Lancet
• 22 Jun: The lenacapavir paradox: why a promising prevention tool raises difficult questions about African HIV response priorities. The Lancet
• 22 Jun: Inclusion of young adolescents in policy development for new tuberculosis vaccines. The Lancet
• 22 Jun: Malaria should worry us more than genetically modified mosquitoes. Devex
• 22 Jun: More than 50 organisations call on the EU to ensure that medicines funded by public money are accessible. Salud por Derecho
• 23 Jun: FDA greenlights generic rifapentine for tuberculosis. MedPage Today
• 23 Jun: US provides Ebola treatment for outbreak in Congo, bringing trials closer. Reuters
• 23 Jun: How Ghana Slashed Child Malaria Deaths by 86%. Health Policy Watch
• 23 Jun: Africa’s progress is real and now we must scale what works. CNBC Africa
• 23 Jun: Four innovations that are changing patients’ lives. MSF
• 24 Jun: The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions. MSF
• 24 Jun: BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine. Nature
• 24 Jun: Gavi and OPEC Fund partner to strengthen regional and local vaccine manufacturing, health financing and security. Gavi
• 24 Jun: UNICEF, Gavi launch call to speed Bundibugyo Ebola vaccine access. Reuters
• 24 Jun: As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon. Health Policy Watch
• 24 Jun: WHO announces 2 trials of experimental drugs in Ebola outbreak. CIDRAP
• 24 Jun: Guarantee Equitable Access to Bundibugyo Ebola Countermeasures and Publish a Transparent Roadmap. The Independent Panel
• 24 Jun: Clinical trial set to test two drugs for fast-growing Ebola outbreak. STAT
• 24 Jun: Antibiotic cocktail made by soil bacteria can kill superbugs. Nature
• 24 Jun: Inspiring, shaping and sustaining an African research & development agenda. Nature
• 24 Jun: Researchers seek better antibiotics for newborn sepsis amid rising drug resistance. Nature
• 24 Jun: Clinical trial priorities, adaptive strategies, and equitable partnerships for the Bundibugyo Ebola outbreak. The Lancet
• 25 Jun: A new malaria mosquito is causing outbreaks in African cites. Here’s where it came from. Gavi
• 25 Jun: Africa CDC triples amount needed to fight Ebola. CIDRAP
• 25 Jun: Europe and Africa set to align global health priorities at EDCTP Forum 2027. Science Business
• 25 Jun: Gates MRI and IQVIA Partner to Advance R&D in Low- And Middle-Income Countries. Gates MRI
• 26 Jun: NIH Budget Cuts Threaten HIV Research. Think Global Health
• 26 Jun: Inside the new political screening that’s stalling NIH grants. Nature
• 27 Jun: Kenya set to benefit as Gavi speeds up Ebola vaccine search. The Star
• 29 Jun: From compost to clinic: the fungus that could let Africa design its own vaccines at a dollar a dose. Gavi
• 29 Jun: New schistosomiasis vaccine induces robust immune memory responses. News Medical
• 29 Jun: Landscape analysis of antimicrobial resistance research in Tanzania. The Lancet
• 30 Jun: Why a surge in sexually transmitted infections in Europe should worry everybody. The Guardian
• 30 Jun: Marburg outbreak is reported in Uganda, threatening to complicate Ebola response in region. STAT
Upcoming Meetings/ Webinars
--------------------------